Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Platform Randomised trial of INterventions against COVID-19 in older peoPLE (PRINCIPLE): Protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk

Hayward G. et al, (2021), BMJ Open, 11

Erratum: System architecture for "support through mobile messaging and digital health technology for diabetes" (SuMMiT-D): Design and performance in pilot and randomized controlled feasibility studies (JMIR Formative Research (2021) 5:3 (e18460) DOI: 10.2196/18460)

Chi Y. et al, (2021), JMIR Formative Research, 5

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074

System architecture for "Support through mobile messaging and digital health technology for diabetes" (SuMMiT-D): Design and performance in pilot and randomized controlled feasibility studies

Chi Y. et al, (2021), JMIR Formative Research, 5

Support through Mobile Messaging and digital health Technology for Diabetes (SuMMiT-D) feasibility trial: strategies and data collection for monitoring of rapid recruitment in a primary care setting

Riga E. et al, (2019), TRIALS, 20